Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 26Lymphoma, Large B-Cell, Diffuse 22Breast Neoplasms 21Lymphoma, Follicular 18Leukemia, Myeloid, Acute 18Burkitt Lymphoma 16Multiple Myeloma 15Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Lymphoma, Large-Cell, Immunoblastic 12Neuroblastoma 11Melanoma 11Myelodysplastic Syndromes 10Lymphoma, B-Cell, Marginal Zone 10Neoplasms, Plasma Cell 9Sarcoma 8Leukemia, Myeloid, Chronic-Phase 8Neutropenia 7Central Nervous System Neoplasms 7Myeloproliferative Disorders 6Medulloblastoma 6Leukemia, Myelomonocytic, Acute 6Congenital Abnormalities 6Waldenstrom Macroglobulinemia 5Neoplasms 5Leukemia, Myelomonocytic, Chronic 5

Interventions

Specimen Handling 5Oxaliplatin 5Leucovorin 5Magnetic Resonance Spectroscopy 4Fluorouracil 4Erlotinib Hydrochloride 4Biopsy 4Trastuzumab 3Capecitabine 3dehydroftorafur 2cobimetinib 2atezolizumab 2Sorafenib 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2MK 2206 2Lapatinib 2Interleukin-12 Subunit p35 2Gemcitabine 2Chemotherapy, Adjuvant 2varlilumab 1trametinib 1tipifarnib 1sargramostim 1peposertib 1pembrolizumab 1motexafin lutetium 1ixabepilone 1entinostat 1cediranib 1binimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Gallbladder Neoplasms × Filgrastim × Clear all
NCT00003296 2013-12-19

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡